Rai, 2000 - Google Patents
STUDY OF THE PROTEIN PROFILE OF SALMONELLA GALLINARUMRai, 2000
View PDF- Document ID
- 7954393414492860369
- Author
- Rai T
- Publication year
External Links
Snippet
Salmonella infections in poultry have been recognised as the primary risk factor associated with the recent increase in public health problems (WHO 1988). There are economic constraints in eradication of Salmonella infection on the poultry farm by the test and …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0291—Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nagy et al. | Immunization of suckling pigs against enteric enterotoxigenic Escherichia coli infection by vaccinating dams with purified pili | |
| ES2279511T3 (en) | ACTIVE IMMUNIZATION USING A SIDEROPHORE RECEPTOR PROTEIN. | |
| Hassan et al. | Control of colonization by virulent Salmonella typhimurium by oral immunization of chickens with avirulent Δcya Δcrp S. typhimurium | |
| Hanes | nontyphoid Salmonella | |
| CA2134835C (en) | Live in ovo vaccine | |
| US20250222089A1 (en) | Klebsiella vaccine and methods of use | |
| Ruffolo et al. | Iron-regulated outer membrane proteins of Pasteurella multocida and their role in immunity | |
| Sizemore et al. | Enterotoxigenic Escherichia coli virulence factors and vaccine approaches | |
| Timms et al. | Laboratory and field trial assessment of protection given by a Salmonella Enteritidis PT4 inactivated, adjuvant vaccine | |
| Chaffer et al. | Vaccination of turkey poults against pathogenic Escherichia coli | |
| IE60324B1 (en) | Vaccine against e. coli septicaemia in poultry | |
| WO2020043637A1 (en) | Combination vaccine | |
| Rai | STUDY OF THE PROTEIN PROFILE OF SALMONELLA GALLINARUM | |
| EP2911688B1 (en) | Cross-protecting salmonella vaccines | |
| TW200418874A (en) | Passive vaccine for the prevention of campylobacter colonization, and its preparation method | |
| RU2683027C2 (en) | Polyvalent combined immunizing and/or therapeutic preparation for use in bacterial infections or food poisoning, particularly salmonellosis, method for production of this preparation, its use and vaccine comprising this preparation | |
| Futoma-Kołoch et al. | Searching for outer membrane proteins typical of serum-sensitive and serum-resistant phenotypes of Salmonella | |
| Mishra et al. | Comparative efficacy of various toxoids against salmonellosis in poultry | |
| Abhilash | IMMUNOGENICITY AND PROTECTIVE EFFICACY OF A NOVEL INACTIVATED/KILLED PASTEURELLA MULTOCIDA A: 1 VACCINE AGAINST FOWL CHOLERA IN CHICKEN | |
| Gupta et al. | Comparative protein profiles of Salmonella and E. coli | |
| BR112015025288B1 (en) | VACCINE COMPOSITION FOR USE IN VACCINATING CHICKENS AGAINST CAMPYLOBACTER | |
| Gast | Pre-harvest measures to control Salmonella in laying hens | |
| BR112020015166A2 (en) | MANIPULATED PROTEINS AND METHODS OF USE | |
| Dibb-Fuller | The contribution of sef14, sef17, sef21 and flagella to the pathogenesis of salmonella enteritidis in poultry | |
| Lockman | Motility and adherence as Salmonella typhimurium virulence factors: The pathogenesis of fla, mot, andfim mutants in murine typhoid fever |